METASTATIC BRCA HEREDITARY BREAST CARCINOMA

Clinical trials for METASTATIC BRCA HEREDITARY BREAST CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new METASTATIC BRCA HEREDITARY BREAST CARCINOMA trials appear

Sign up with your email to follow new studies for METASTATIC BRCA HEREDITARY BREAST CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Double attack on tough cancers: early trial tests combo for patients out of options

Disease control Ongoing

This early-stage trial is testing a combination of two drugs, niraparib and dostarlimab, for people with advanced breast, ovarian, pancreatic, or related cancers that have a specific genetic change (BRCA mutation) and have stopped responding to standard treatments. The goal is to…

Matched conditions: METASTATIC BRCA HEREDITARY BREAST CARCINOMA

Phase: PHASE1 • Sponsor: University of Washington • Aim: Disease control

Last updated Mar 23, 2026 15:16 UTC

METASTATIC BRCA HEREDITARY BREAST CARCINOMA

Get alerted when new METASTATIC BRCA HEREDITARY BREAST CARCINOMA trials appear

Double attack on tough cancers: early trial tests combo for patients out of options